Literature DB >> 31430434

Differential long-term regulation of TAS2R14 by structurally distinct agonists.

Jung A Woo1, Maria Castaño2, Ashley Goss2, Donghwa Kim2, Eric M Lewandowski3, Yu Chen3, Stephen B Liggett1,2.   

Abstract

Bitter taste receptor-14 (TAS2R14) is a GPCR also expressed on human airway smooth muscle cells, which signals to intracellular [Ca2+], resulting in relaxation of the airway, and is a novel target for bronchodilators. Here, we examine long-term, agonist-promoted down-regulation of TAS2R14 expression because tachyphylaxis would be an undesirable therapeutic characteristic. Five TAS2R structurally distinct full agonists were studied to ascertain biasing away from down-regulation. Agonist exposure for 18 h caused minimal desensitization by diphenhydramine (DPD) compared with ∼50% desensitization with all other agonists. Agonists evoked β-arrestin recruitment to TAS2R14, which was not seen with a phosphoacceptor-deficient mutant, TAS2R14-10A. All agonists except for DPD also caused subsequent TAS2R14 internalization and trafficking via early and late endosomes to down-regulation. TAS2R14-10A failed to undergo these events with any agonist. Molecular docking showed that DPD has specific interactions deep within a binding pocket that are not observed with the other agonists, which may lock the receptor in a conformation that does not internalize and therefore does not undergo down-regulation. Thus, TAS2R14 is subject to β-arrestin-mediated internalization and subsequent down-regulation with chronic exposure to most agonists. However, by manipulating the agonist structure, biasing toward G-protein coupling but away from long-term down-regulation can be achieved.-Woo, J. A., Castaño, M., Goss, A., Kim, D., Lewandowski, E. M., Chen, Y., Liggett, S. B. Differential long-term regulation of TAS2R14 by structurally distinct agonists.

Entities:  

Keywords:  [Ca2+]i; desensitization; down-regulation; internalization; β-arrestin

Mesh:

Substances:

Year:  2019        PMID: 31430434      PMCID: PMC6902689          DOI: 10.1096/fj.201802627RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

Review 1.  Seven-transmembrane-spanning receptors and heart function.

Authors:  Howard A Rockman; Walter J Koch; Robert J Lefkowitz
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Heterogeneity of therapeutic responses in asthma.

Authors:  J M Drazen; E K Silverman; T H Lee
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

Review 3.  Hierarchical docking of databases of multiple ligand conformations.

Authors:  David M Lorber; Brian K Shoichet
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

4.  Pleiotropic beta-agonist-promoted receptor conformations and signals independent of intrinsic activity.

Authors:  Steven M Swift; Mary Rose Schwarb; Kathryn A Mihlbachler; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

Review 5.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

Authors:  Natasha C Salazar; Juhsien Chen; Howard A Rockman
Journal:  Biochim Biophys Acta       Date:  2007-02-20

6.  The molecular receptive ranges of human TAS2R bitter taste receptors.

Authors:  Wolfgang Meyerhof; Claudia Batram; Christina Kuhn; Anne Brockhoff; Elke Chudoba; Bernd Bufe; Giovanni Appendino; Maik Behrens
Journal:  Chem Senses       Date:  2009-12-18       Impact factor: 3.160

Review 7.  Effects of endocytosis on receptor-mediated signaling.

Authors:  Roshanak Irannejad; Nikoleta G Tsvetanova; Braden T Lobingier; Mark von Zastrow
Journal:  Curr Opin Cell Biol       Date:  2015-06-06       Impact factor: 8.382

8.  Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

Authors:  S Shrewsbury; S Pyke; M Britton
Journal:  BMJ       Date:  2000-05-20

9.  Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs.

Authors:  M G Eason; M T Jacinto; S B Liggett
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

10.  Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta-agonist.

Authors:  J Turki; S A Green; K B Newman; M A Meyers; S B Liggett
Journal:  Am J Physiol       Date:  1995-11
View more
  6 in total

1.  Identification and Characterization of Novel Bronchodilator Agonists Acting at Human Airway Smooth Muscle Cell TAS2R5.

Authors:  Donghwa Kim; Steven S An; Hong Lam; James W Leahy; Stephen B Liggett
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

2.  The stability of tastant detection by mouse lingual chemosensory tissue requires Regulator of G protein Signaling-21 (RGS21).

Authors:  Adam B Schroer; Kayla W Branyan; Joshua D Gross; Paul D Chantler; Adam J Kimple; Aurelie Vandenbeuch; David P Siderovski
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 3.160

Review 3.  Therapeutic potential and challenges of bitter taste receptors on lung cells.

Authors:  Stanley Conaway; Ajay P Nayak; Deepak A Deshpande
Journal:  Curr Opin Pharmacol       Date:  2020-08-15       Impact factor: 5.547

4.  Pharmacology of T2R Mediated Host-Microbe Interactions.

Authors:  Manoj Reddy Medapati; Anjali Y Bhagirath; Nisha Singh; Prashen Chelikani
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Modulation of Food Intake by Differential TAS2R Stimulation in Rat.

Authors:  Carme Grau-Bové; Alba Miguéns-Gómez; Carlos González-Quilen; José-Antonio Fernández-López; Xavier Remesar; Cristina Torres-Fuentes; Javier Ávila-Román; Esther Rodríguez-Gallego; Raúl Beltrán-Debón; M Teresa Blay; Ximena Terra; Anna Ardévol; Montserrat Pinent
Journal:  Nutrients       Date:  2020-12-10       Impact factor: 5.717

6.  Identification and characterization of an atypical Gαs-biased β2AR agonist that fails to evoke airway smooth muscle cell tachyphylaxis.

Authors:  Donghwa Kim; Alina Tokmakova; Lauren K Lujan; Hannah R Strzelinski; Nicholas Kim; Maliheh Najari Beidokhti; Marc A Giulianotti; Amirhossein Mafi; Jung-A A Woo; Steven S An; William A Goddard; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.